Sep 26, 2019
The advances of medical science have been nothing short of remarkable over the last few decades. Illnesses such as cancer, heart disease and diabetes have become chronic illnesses. Proper ongoing medication and regular physician interaction have resulted in longer and healthier lives. Yet, the emotional and psychological costs of living with these disease states are just beginning to be understood in healthcare. As the grandfather of two type-I diabetics, I have watched first-hand how the disease is an ever present factor in their lives - 7/24/365. There is no escaping the constant reminder that their lives differ from that of...
Read MoreFiled Under: cancer drugs cost, changes in healthcare, high-cost drugs, Insider, medical access
Aug 28, 2019
https://youtu.be/Cxtx_5bbvPQhttps://youtu.be/zP1g70sXRuEhttps://youtu.be/nxfAcKxF6BA
Read MoreFiled Under: cancer drugs cost, cancer treatments, high-cost drugs, insurance coverage, medications, overmedication, polypharmacy, Specialty Drugs, understanding insurance
Aug 1, 2019
Hemophilia is a rare blood clotting disorder that affects approximately 20,000 people in the United States and an estimated total of 400,000 people worldwide. The symptoms can range from mild to severe; but keeping it under control often dictates a need for prophylactic or preventative treatment to ensure that bleeding does not become an issue. Bleeding issues often lead to additional medical care, including hospital stays, which means additional costs for employers and the insured. Due to its rarity, the treatments are often extremely expensive. Hemophilia not only an impact upon a person's quality of life, but can be quite the financial...
Read MoreFiled Under: changes in healthcare, Corporate Benefits, hemophilia, high-cost drugs, medications, negotiate medical bills, Specialty Drugs
Jul 25, 2019
Hemophilia is a rare clotting disorder that causes blood to not clot properly. It causes more than normal bleeding when someone is injured and can be life threatening. This very rare and usually inherited disorder affects approximately 20,000 people in the United States. The severity of the disease can vary dramatically between affected individuals and the severity, from mild to severe would dictate the level of medical care one needs. It can not only be financially costly, something we will discuss in part 2, but also physically costly; which is what is discussed in part one of this article series. The basics...
Read MoreFiled Under: changes in healthcare, Corporate Benefits, high-cost drugs, medications, negotiate medical bills, Specialty Drugs
Jul 12, 2019
The pharmaceutical side of oncology and other specialty drugs is a multi-billion dollar business. This is one of the highest cost segments of pharmaceuticals to patients and insurance companies, and it is one of the highest profit areas for the pharmaceutical companies. In 2016, specialty drugs made up 40% of the $450 billion pharmaceutical market, which translates into $180 billion. This staggering amount of money is bad enough in itself, but what if I told you that some of those medications that make up that $180 billion was being wasted in hospitals and other healthcare centers every single day? How Can...
Read MoreFiled Under: cancer drugs cost, cancer treatments, elder care, Health Management, high-cost drugs, medications, overmedication, polypharmacy, Specialty Drugs, understanding insurance